Study of Enfuvirtide in HIV-Positive Subjects
NCT00086710 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2005-06-24
Summary
A total of 26 patients will be admitted to the clinic where they will be dosed with each injection device. There will be a 7-day washout between doses and a 7-10 day follow-up period.
Conditions
- HIV Infections
- AIDS
Interventions
- DRUG
-
Fuzeon
Sponsors & Collaborators
- collaborator INDUSTRY
-
Trimeris
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.
NCT00326963 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
NCT01902615 ·Status: COMPLETED
-
Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection
NCT02733419 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection
NCT02582983 ·Status: COMPLETED ·Phase: PHASE4
-
Fuzeon Viral Decay Pilot Study
NCT00334022 ·Status: COMPLETED ·Phase: NA
-
INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
NCT00615134 ·Status: COMPLETED ·Phase: PHASE2
-
QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection
NCT00232908 ·Status: COMPLETED ·Phase: PHASE4
-
Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
NCT00365612 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus
NCT00102934 ·Status: UNKNOWN ·Phase: NA
-
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
NCT00966160 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
NCT07053384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection
NCT00337701 ·Status: COMPLETED ·Phase: PHASE4
-
Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations
NCT00011089 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
NCT01040091 ·Status: COMPLETED ·Phase: PHASE1
-
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF
NCT02121795 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
NCT00051831 ·Status: COMPLETED ·Phase: NA
-
Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients
NCT00106379 ·Status: COMPLETED ·Phase: PHASE4
-
A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1
NCT00100984 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection
NCT02176135 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)
NCT06513312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cohort Study for Patients Using Fuzeon (Enfuvirtide)
NCT00216359 ·Status: UNKNOWN
-
ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
NCT00461266 ·Status: WITHDRAWN ·Phase: PHASE4
-
Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
NCT00016588 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
NCT00937729 ·Status: TERMINATED
-
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
NCT06101342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2